CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in CytoDyn Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q3 2021
- Shares held
- 610.3K
- +3.35K (+0.6%) vs. Q3 2021
- Total value
- $568.8K
- −$643.2K (−53.1%) vs. Q3 2021
- New holders
- 3
- 1 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYDY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $35.2K |
| Q1 2026 | 9 | $87.1K |
| Q4 2025 | 8 | $91.0K |
| Q3 2025 | 11 | $120.5K |
| Q2 2025 | 11 | $76.4K |
| Q1 2025 | 11 | $64.7K |
| Q4 2024 | 10 | $29.8K |
| Q3 2024 | 9 | $64.6K |
| Q2 2024 | 11 | $37.4K |
| Q1 2024 | 12 | $47.9K |
| Q4 2023 | 11 | $92.5K |
| Q3 2023 | 9 | $41.2K |
| Q2 2023 | 12 | $146.5K |
| Q1 2023 | 11 | $162.5K |
| Q4 2022 | 12 | $110.8K |
| Q3 2022 | 13 | $315.0K |
| Q2 2022 | 13 | $208.3K |
| Q1 2022 | 16 | $191.5K |
| Q4 2021 | 18 | $568.8K |
| Q3 2021 | 16 | $1.21M |
| Q2 2021 | 20 | $1.43M |
| Q1 2021 | 21 | $2.11M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding CytoDyn Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Financial Group LLC | 500 | $0 | 0.00% | +500 | New |
| Holloway Wealth Management, LLC | – | $3.00K | 0.00% | – | – |
| IFP Advisors, Inc | 4,150 | $4.00K | 0.00% | 00.0% | Unchanged |
| Caz Investments LP | 4,000 | $4.00K | 0.01% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 9,488 | $9.00K | 0.00% | 00.0% | Unchanged |
| Inverness Counsel LLC | 10,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 12,500 | $12.0K | 0.00% | −4,500−26.5% | Reduced |
| United Community Bank | 15,000 | $14.8K | 0.01% | +15,000 | New |
| FineMark National Bank & Trust | 15,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| S.A. Mason LLC | 19,000 | $19.0K | 0.01% | 00.0% | Unchanged |
| Captrust Financial Advisors | 21,076 | $21.0K | 0.00% | −7,550−26.4% | Reduced |
| Monograph Wealth Advisors, LLC | 24,000 | $24.0K | 0.01% | +24,000 | New |
| Moloney Securities Asset Management, LLC | 28,025 | $28.0K | 0.00% | +1,000+3.7% | Added |
| Next Capital Management LLC | 37,500 | $37.0K | 0.03% | 00.0% | Unchanged |
| Diversified Trust Co | 45,790 | $45.0K | 0.00% | 00.0% | Unchanged |
| L & S Advisors Inc | 50,500 | $50.0K | 0.01% | −100−0.2% | Reduced |
| Capital Advantage, Inc. | 91,000 | $53.0K | 0.01% | 00.0% | Unchanged |
| Firsthand Capital Management, Inc. | 222,730 | $220.0K | 0.08% | 00.0% | Unchanged |
| MAI Capital Management | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |